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Abstract 
 A simple and high efficient way for the synthesis of gamma-aminobutyric acid (GABA) was developed by using 
engineered Escherichia coli as whole-cell biocatalyst from l-glutamic acid (l-Glu). Codon optimization of Lactococ-
cus lactis GadB showed the best performance on GABA production when middle copy-number plasmid was used as 
expression vector in E. coli BW25113. The highest production of GABA reached 308.96 g L−1 with 99.9 mol% conver-
sion within 12 h, when E. coli ΔgabAB (pRB-lgadB) concentrated to an OD600 of 15 in 3 M l-Glu at 45 °C. Furthermore, 
the strain could be reused at least three cycles in 2 M crude l-Glu with an average productivity of 40.94 g L−1 h−1. The 
total GABA yield reached 614.15 g L−1 with a molar yield over 99 %, which represented the highest GABA production 
ever reported. The whole-cell bioconversion system allowed us to achieve a promising cost-effective resource for 
GABA in industrial application.
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Background
Gamma-aminobutyric acid (GABA) is a four-carbon 
non-protein amino acid that is ubiquitous in bacteria, 
plants and vertebrates (Diana et  al. 2014). GABA has 
been used extensively in functional foods and pharma-
ceuticals, because it can act as an efficient neurotransmit-
ter in vertebrates (Wong et al. 2003). In addition, GABA 
can converted into 2-pyrrolidone, an intermediate in the 
synthesis of nylon 4 and agrochemicals, which broaden 
its industrial applications (Park et  al. 2013; Yamano 
et  al. 2013). Nowadays, the majority of the GABA was 
chemically synthesized from 4-chlorobutyronitrile, 
2-pyrrolidone or 4-butyrolactone, however, chemical 
synthesis often resulted in environmentally unfriendly 
and cost-ineffective purification (Additional file 1: Table 
S1). Therefore, a strategy for economical production of 
biologically produced GABA for an industrial scale is 
eagerly demanded.
GABA is a natural metabolic intermediate in organ-
isms, which can be synthesized via decarboxylation 
of glutamate by glutamate decarboxylase (GAD; EC 
4.1.1.15) (Dhakal et al. 2012). There are many reports on 
the production of GABA by direct fermentation using 
natural or recombinant microorganisms (Pham et  al. 
2015; Shi et  al. 2013). Among them, lactic acid bacte-
ria (LAB) who contain inherent GABA synthesis path-
way, produced high level of GABA in MSG-containing 
medium (Kook and Cho 2013; Li et  al. 2010). However, 
an accompanying separation processes needed to be 
developed, and these processes were too complex to 
increase the cost of GABA purification (Kang et al. 2013). 
Recently, GABA could efficiently converted from gluta-
mate (MSG) and l-glutamic acid (l-Glu) using purified 
GAD or microorganisms expressing GAD (Kang et  al. 
2013; Lammens et al. 2009). Together with high efficiency 
of MSG/l-Glu fermentation, bioconversion of MSG/l-
Glu into GABA was more economically than the fermen-
tative methods (Hermann 2003).
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Glutamate decarboxylase, a pyridoxal 5′-phosphate 
(PLP)-dependent enzyme, is a key factor for the biocon-
version. Due to its role in bacterial glutamate-based acid 
resistance system, most natural GADs exhibited their 
highest decarboxylase activity only under the acidic con-
ditions (De Biase and Pennacchietti 2012; Kanjee and 
Houry 2013). This characteristic of pH-response was dis-
advantageous to GAD used in producing GABA, because 
the pH increase as the reaction proceeded would inacti-
vate GAD and limited the conversion (Gut et  al. 2006). 
Since the crystal structures of E. coli GADs revealed the 
structural basis for its optimal activity at acidic pH, sev-
eral mutants with high activity toward more alkaline pH 
values have been constructed to improve GABA produc-
tion (Choi et al. 2015; Shi et al. 2014; Thu Ho et al. 2013). 
On the other hand, hydrochloric acid, sodium acetate 
buffer and acidic cation-exchange resins were used to 
maintain the acidic condition during reaction from MSG 
into GABA, and the conversion efficiency were remark-
ably improved (Dinh et al. 2014; Park et al. 2013; Plokhov 
et  al. 2000). However, these methods were also unsatis-
factory for the following separation and purification of 
GABA due to the introduction of the high amount of 
salts or resins. In recent years, l-Glu was widely applied 
as substrate for keeping the acidic pH in non-buffered 
reaction with purified or immobilized GAD (Kang et al. 
2013; Lammens et al. 2009; Yamano et al. 2013). Despite 
of the high conversion yield and the simple downstream 
separation, it was not suitable for industrial scale because 
of the tedious preparation of purified GAD and the 
requirement of expensive cofactor PLP.
In comparison to the purified enzymes method, whole-
cell bioconversion is an attractive way due to its great 
efficiency, relatively easy preparation and low cost, which 
is of particular interest for large-scale applications (Schu-
urmann et  al. 2014). In that case, E. coli was the most 
common whole-cell baiocatlyst (Tam et  al. 2012; Vo 
et  al. 2013; Yamano et  al. 2013). For example, Plokhov 
et  al. used recombinant E. coli strain as whole-cell bio-
catalyst, 138 g GABA was achieved from 200 g l-Glu at 
a conversion yield of 98.5 % (Plokhov et al. 2000); Naoko 
et al. used E. coli NBRC 3806 as the whole-cell biocata-
lyst, 303.7 g GABA was produced from 560 g l-Glu via 
repeating 14 times (Yamano et  al. 2013). Except for E. 
coli, Bacillus subtilis and Lactobacillus brevis resting cell 
were also used as the whole-cell biocatalyst, however, 
the production was not so attractive for industrial scale 
(Zhang et al. 2012, 2014). Moreover, the presence of the 
cell envelopes was able to stabilize the intracellular gluta-
mate decarboxylase and made it less material adsorption.
In this study, we constructed a recombinant E. coli to 
produce GABA by overexpressing L. lactis gadB. Then, 
an efficient whole-cell biocatalytic process for GABA 
production from l-Glu was developed by optimizing 
reaction temperatures, biocatalyst and substrate concen-
trations. The competing pathway was removed to reduce 
the degradation of GABA. Finally, crude l-Glu provided 
by Wuyi Gourmet Powder Factory was used for convert-
ing into GABA to investigate the possibility of connect-




The plasmids and bacterial strains used in this study 
were listed in Table  1. E. coli BW25113 and its deriva-
tive strains were used for GADs expression and GABA 
production, while E. coli DH5α was used for gene clon-
ing and plasmid maintenance. Plasmid pCP20 was used 
to remove the kan gene, and the P1 phage was used to 
delete the gadB gene in E. coli ΔgadA (Baba et al. 2006; 
Thomason et al. 2007).
Construction of plasmids
Standard methods were used for PCR, ligation, plasmid 
construction, extraction of plasmid DNA and genomic 
DNA and transformation (Green and Sambrook 2012). 
DNA polymerases, restriction endonucleases, T4 DNA 
ligase, and vector were purchased from NEB (New Eng-
land BioLabs, China).
The gadB genes were synthesized according to the 
sequences from genomic DNA of three different strains, 
including L. brevis, L. lactis and L. plantarum with codon 
optimization (GenBank accession AIC75915; AAK05388; 
EFK28268). Nucleotide sequences of three codon-opti-
mized gadB genes were submitted to GenBank under the 
accession number KT966875, KT966877 and KT966876. 
gadB genes, with the restriction sites XhoI upstream and 
SpeI downstream, were digested by XhoI and SpeI, and 
then ligated into the plasmids.
Gene disruption
The gadA and gadB double mutant was disrupted by P1 
transduction (Thomason et  al. 2007). Briefly, the phage 
P1 was grown on the donor strain ΔgadB containing the 
transferable elements, and the resulting phage lysate was 
used to infect the recipient E. coli ΔgadA strain. The kan 
gene was eliminated using the plasmid pCP20, which 
encodes the FLP recombinase. The mutant strain was 
confirmed by PCR amplification with primers (forward, 
5′-TTAAACACGAGTCCTTTGC-3′ and reverse, 5′- 
AGCAGGAAGAAGACTAATGA-3′) and sequencing.
E. coli cultivation in shake flasks
Escherichia coli strains were grown in LB medium 
(10  g  L−1 tryptone, 5  g  L−1 NaCl, and 5  g  L−1 yeast 
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extract) containing 50 mg L−1 streptomycin at 30 °C with 
shaking at 200  rpm. Then, 1  % pre-culture was trans-
ferred into 50  mL of ZYM medium (Studier 2005) with 
50 mg L−1 streptomycin in 250 mL shake flask for GADs 
expression. Cells were cultivated at 30  °C for 16  h with 
shaking at 200 rpm.
Fed‑batch cultivation
For seed cultures, the E. coli was inoculated into 350 mL 
of LB medium containing 50 mg L−1 streptomycin in a 
1 L flask at 30 °C for 8 h with shaking at 200 rpm. Then, 
seed cultures was transferred into 35  L of fresh basal 
medium (5 g L−1 yeast extract, 9 g L−1 KH2PO4, 4 g L−1 
(NH4) 2HPO4 and 0.6 g L−1 MgSO4) containing 20 g L−1 
glucose and 50 mg L−1 streptomycin in a 50 L jar bio-
reactor. In the fed-batch cultivation, glucose concentra-
tion was maintained at 0.5 g L−1 in the broth to avoiding 
the glucose limitation. During the cultivation, tem-
perature was maintained at 30  °C; pH was maintained 
at pH 6.7 by adding ammonia water; dissolved oxygen 
was maintained at 20 % (v/v) by automatically increas-
ing the agitation speed up to 600 rpm with 1.0 vvm air 
flow rate.
Bioconversion conditions
After induction, the cells were collected by centrifuga-
tion at 8000×g for 10 min and then resuspended in 0.1 M 
sodium acetate buffer (pH 4.6) with MSG or deionized 
water (DW) with l-Glu at appropriate concentration. 
The reaction mixtures were adjusted to different tem-
peratures, cell densities and substrate concentrations 
to improve the GABA production. After the process 
was optimized, the cells were incubated at 45  °C with 
the addition of 3  M Glu to investigate the production 
of GABA. The same batch of cells were used three runs 
in 2  M crude l-Glu solution for each time to produce 
GABA. For each round of the cycling reaction, cells were 
harvested and adjusted to OD600 of 15, then mixed with 
l-Glu directly.
Analytical methods
The cell density was estimated by measuring the opti-
cal density at 600  nm (OD600). One unit of OD600 cor-
responds to a wet cell weight of 0.83  ±  0.01  g  L−1. 
Expression of recombinant GADs was analyzed by 12 % 
sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE).
Table 1 The strains and plasmids used in this study
Strains or plasmids Descriptions References
E. coli strains
 DH5α F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupGΦ80dlacZΔM15, Δ(lacZYA-argF)U169, 
hsdR17(rK− mK+), λ−
Lab stock
 BW25113 F−, Δ(araBAD)567, ΔlacZ4787(::rrnB3), λ
−, rp h-1, Δ(rhaBAD)568, hsdR514 Baba et al. (2006)
 ΔgadA JW3485, gadA null mutant of BW25113 Baba et al. (2006)
 ΔgadB JW1488, gadB null mutant of BW25113 Baba et al. (2006)
 ΔgadT JW2637, gabT null mutant of BW25113 Baba et al. (2006)
 ΔgadAB gadA and gadB null mutant of BW25113 This study
Plasmids
 pCP20 Flp+, λcI857+, λ PR Rep(pSC101 ori)ts, Apr, Cmr Datsenko and Wanner (2000)
 pYB1S p15A ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pRB1S RSF1020 ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pAB1S colA ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pDB1S cloDF13 ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pSB1S pSC101 ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pUB1S colE1 ori, arabinose-inducible araBAD promoter, Strr Lab stock
 pYB-bgadB pRB1S with gadB from L. brevis BH2 This study
 pYB-pgadB pRB1S with gadB from L. plantarum ATCC 14917 This study
 pYB-lgadB pRB1S with gadB from L. lactis IL1403 This study
 pAB-lgadB pAB1S with gadB from L. lactis IL1403 This study
 pDB-lgadB pDB1S with gadB from L. lactis IL1403 This study
 pSB-lgadB pSB1S with gadB from L. lactis IL1403 This study
 pUB-lgadB pUB1S with gadB from L. lactis IL1403 This study
 pRB-lgadB pYB1S with gadB from L. lactis IL1403 This study
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The concentrations of GABA and l-Glu were meas-
ured by HPLC with the phenylisothiocyanate derivation 
method, equipped with Hypersil GOLD C18 analysis 
column (250  mm ×  4.6  mm, 5  μm, Thermo). The deri-
vatization reagent consisting of phenylisothiocyanate/tri-
ethylamine/acetonitrile (0.02:0.18:2.3) solution (2.5  mL) 
was added to 2.5 mL of the supernatant. The mixture was 
incubated at 40  °C for 60  min. Then, 5  mL hexane was 
added to stop the reaction, shaken and aside for 10 min. 
The reacted solutions was analyzed at 40 °C using a linear 
gradient of two mobile phases (eluent A: acetonitrile; elu-
ent B: 50 mM sodium acetate, linear gradient of 0–70 % 
eluent B in 15  min) at a flow rate of 0.8  mL  min−1 and 
monitored at 254 nm (Takeda et al. 2012). The standard 
curves for GABA and l-Glu (Sigma, Missouri, USA) were 
determined using the same procedure.
Results and discussion
Construction of recombinant E. coli for the production 
of GABA
Initially, MSG was used as the substrate for whole-
cell bioconversion of wild-type E. coli. However, only 
7.86 g L−1 GABA was produced within 6 h, indicating the 
wild-type E. coli was not suitable as whole-cell biocata-
lysts for conversion into GABA. Thus, we constructed 
recombinant E. coli strains by overexpressing codon-
optimized L. lactis GadB, L. plantarum GadB and L. 
brevis GadB from middle copy-number plasmid (pYB1S) 
under the regulation of ParaBAD promoter. The SDS-PAGE 
result showed the three gadB genes were successfully 
expressed, and the GadB proteins were produced with 
high solubility (Additional file 1: Fig. S1).
The effect of three candidate strains with different 
GadB genes on production of GABA was examined. We 
resuspended the strains with an OD600 of 30 in 0.1  M 
sodium acetate buffer (pH 4.6) containing 1 M MSG for 
bioconversion at 37  °C. As a result, recombinant E. coli 
BW25113 expresses L. lactis GadB was the most active 
whole-cell biocatalyst for GABA production, which 
resulted in the synthesis of 45.58  g  L−1 GABA with a 
44.2  mol% conversion within 6  h (Fig.  1a). The other 
two recombinant E. coli harboring L. brevis GadB and L. 
plantarum GadB produced lower GABA concentration 
of 31.12 and 18.97 g L−1, respectively.
Glutamic acid is a good buffer for bioconversion
High concentration of MSG and GABA that contained 
ionizable alpha-amino groups made the bioconver-
sion reaction maintain at near-neutral pH environment, 
which was beyond the active range of wild-type GAD. 
Instead of using buffer solution with the MSG in the 
reaction, we applied pure l-Glu to achieve acidic pH 
at the start of the bioconversion. Three recombinant E. 
coli strains produced GABA in water with adding 1  M 
l-Glu at one time. At the beginning, l-Glu was partially 
dissolved in water, then dissolved better as the conver-
sion proceeded. Finally, l-Glu was dissolved completely 
in the system, which meant almost all of the l-Glu was 
converted into GABA. As we expected, the three strains 
with l-Glu as the substrate showed higher efficiency 
and higher molar yield of GABA production than using 
MSG (Fig.  1b). The highest production of GABA was 
achieved at 101.16 g L−1 (0.98 M) using recombinant E. 
coli expressing L. lactis GadB, with a 220 % improvement 
compared to that obtained in 1 M MSG buffer (pH 4.6) 
within 6  h. Based on these results, recombinant E. coli 
expressing L. lactis GadB was selected for further inves-
tigations on the production of GABA using l-Glu as the 
substrate.
Fig. 1 Time profiles of GABA produced in a MSG buffer and b l-Glu 
solution by E. coli BW25113 expressing different GadB. Conver-
sions were performed at 37 °C and 25 g wet cell per liter. Data are 
presented as the mean ± SD values from three independent experi-
ments. Square, down triangle, diamond and circle symbolize the E. coli 
BW25113 and recombinant E. coli BW25113 harboring pYB-pgadB, 
pYB-bgadB and pYB-lgadB, respectively
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Synthesis of GABA by recombinant E. coli harboring 
different plasmids
To provide appropriate expression level of L. lactis 
gadB in E. coli for GABA production, six different plas-
mids from a relatively low copy-number (~5) to high 
copy-number (~300) were applied. Recombinant E. coli 
BW25113 strains harboring pSB-lgadB, pAB-lgadB, pYB-
lgadB, pRB-lgadB, pDB-lgadB and pUB-lgadB were inves-
tigated for the conversion of l-Glu into GABA (Fig.  2). 
To our surprise, the strain with the highest copy-number 
plasmid (E. coli BW25113 harboring pUB-lgadB) was 
only produced 80.33 g L−1 GABA within 6 h. The highest 
GABA production (102.19 g L−1) was achieved by recom-
binant E. coli harboring middle copy-number plasmid 
(pRB-lgadB) within 5 h with a space–time productivity of 
20.44  g  L−1  h−1. The result indicated a moderate rather 
strong expression of GAD was efficient for GABA pro-
duction, and the soluble expression levels of GAD were 
not correlated with the production and the productivity 
of GABA (Additional file  1: Fig. S2). Moreover, the low 
copy-number indeed had the negative effect on GABA 
production, for example, recombinant E. coli harbor-
ing pSB-lgadB (the lowest copy-number) produced only 
42.21 g L−1 GABA within 6 h.
Optimization of bioconversion system for GABA synthesis
As previously reported, the temperature of the reaction 
was a core factor for glutamate decarboxylase activ-
ity (Lammens et  al. 2009; Plokhov et  al. 2000; Zhang 
et  al. 2014). Thus, the conversion efficiency of E. coli 
BW25113 harboring pRB-lgadB was examined at five 
different temperature conditions (33, 37, 41, 45 and 
50  °C) (Fig.  3a). The highest volumetric productivity of 
GABA (34.04  g  L−1  h−1) was obtained at 45  °C, which 
was 1.67 times higher than previous study at 37  °C 
(20.44 g L−1 h−1). Consequently, 102.13 g L−1 GABA with 
a molar yield of 99.1 % was produced within 3 h at 45 °C, 
and this result consisted with the optimum temperature 
of purified GAD (EC 4.1.1.15) in L. lactis (Nomura et al. 
1999).
To improve the total production of GABA during 
whole-cell bioconversion, the cell productivity was also 
investigated (Fig.  3b). Comparing with the strain con-
centrated to OD600 of 30 in previous study, the cell pro-
ductivity of GABA was significantly improved as the cell 
amount decreasing. The cell productivity increased to a 
peak (9.28 g/g wet cell) using the strain with OD600 of 5, 
however, the GABA production only reached 38.53 g L−1 
with 37.4 mol% conversion. Despite of a little lower cell 
productivity (8.13  g/g wet cell), the GABA production 
was achieved at 101.26 g L−1 with 98.2 mol% conversion 
using the strain with OD600 of 15. Furthermore,GABA 
yield only increased a little (1.71–2.33  g  L−1) when the 
strain concentrated to OD600 over 15, while the cell pro-
ductivity fell a lot (6.2–4.1  g/g wet cell). Therefore, the 
strain with an OD600 of 15 was more applicable for the 
whole cell bioconversion.
Effect of substrate concentration on GABA production
A series of l-Glu concentrations was used for whole-
cell bioconversion to determine the influence of initial 
l-Glu concentration on GABA production. Time pro-
files of GABA production showed that the GABA yield 
increased with higher initial l-Glu concentration at the 
cost of conversion time (Fig. 4a). The most efficient sys-
tem was controlling the initial concentrations of l-Glu 
less than 2.5  M, in that case, almost all of l-Glu was 
consumed within 6  h with producing an equal molar 
amount of GABA (Fig. 4b). Interestingly, the presence of 
GABA could promote the solubility of l-Glu, therefore, 
the concentration of l-Glu increased in the early stages 
(Additional file  1: Fig. S3). When the initial l-Glu con-
centration increased to 3  M, the conversion time pro-
longed to 12  h for consuming almost all the l-Glu, and 
the production reached 303.75 g L−1 with 98.2 mol% con-
version (Fig. 5). Further increase in the initial concentra-
tion, l-Glu could not be completely converted to GABA 
even though longer conversion times (up to 24  h) was 
spent (data not shown). As a result, the highest volumet-
ric productivity of GABA (41.12 g L−1 h−1) was achieved 
using 2  M l-Glu as the substrate, which resulted in the 
production of 205.61  g  L−1 GABA with a conversion of 
99.7 mol%. For the record, this is the highest volumetric 
productivity level of GABA produced by whole-cell bio-
conversion from l-Glu, even compared with conversion 
using the purified or immobilized GAD (35  g  L−1  h−1) 
(Kang et al. 2013; Lammens et al. 2009).
Fig. 2 Production of GABA by recombinant E. coli harboring different 
plasmids. Square, circle, down triangle, diamond, hexagon and up 
triangle symbolize the recombinant E. coli harboring pRB-lgadB, pYB-
lgadB, pDB-lgadB, pUB-lgadB, pAB-lgadB and pSB-lgadB, respectively
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Effect of blocking competitive pathways in GABA 
production
It is worth noting that the GABA concentration strik-
ingly degraded from 303.75 g L−1 obtained from 3 M Glu 
within 12 h to 289.07 g L−1 during 30 h (Fig. 5). GABA 
aminotransferase (GabT), which directed GABA to 
the TCA cycle, was considered to be the main cause of 
GABA degradation (Tam et  al. 2012). Therefore, E. coli 
ΔgabT harboring pRB-lgadB was constructed as whole-
cell biocatalyst to investigate GABA production. Recom-
binant E. coli ΔgabT indeed impeded the degradation of 
GABA, but it produced 273.96 g L−1 GABA by consum-
ing 89 % of 3 M l-Glu within 42 h, which was only 25.9 % 
of the volumetric productivity obtained from the best 
strain (25.44 g L−1 h−1). The result was similar with previ-
ously reported, because E. coli ΔgabT caused a metabolic 
burdens, which lead to lower cellular metabolic activity 
(Tam et al. 2012).
Interestingly, when the chromosomal gadA, gadB or 
both were knocked out, the degradation of GABA was 
Fig. 3 Effects of reaction condition on GABA production. Conver-
sion reactions were performed at different a temperature and b cell 
concentrations with shaking at 200 rpm for 3 h. Data are presented as 
the mean ± SD values from three independent experiments. The bars 
represent GABA concentrations and the square symbols represent a 
volumetric productivity, b cell productivity
Fig. 4 Time profiles of a GABA and b residual l-Glu concentration 
during conversion in different l-Glu concentrations. Conversions were 
performed at 45 °C and 12.5 g wet cell per liter (OD600 of 15). Data are 
presented as the mean ± SD values from three independent experi-
ments. Square, circle, up triangle, down triangle, diamond, left triangle 
and right triangle represent the concentrations of l-Glu: 1, 1.5, 2, 2.5, 3, 
3.5 and 4 M, respectively
Fig. 5 Time profiles of GABA concentration were obtained using vari-
ous strains. Diamond, square, up triangle, circle and down triangle rep-
resent the recombinant E. coli ΔgabT, E. coli BW25113, E. coli ΔgadB, E. 
coli ΔgadA and E. coli ΔgadAB harboring pRB-lgadB, respectively
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also prevented without influence the conversion yield. 
After 42 h, over 303 g L−1 GABA remained in the reac-
tion solution with less than 1  % degradation when 
using the mutant E. coli ΔgadA or E. coli ΔgadB as host 
strain. Meanwhile, E. coli ΔgadAB harboring pRB-lgadB 
achieved the highest GABA concentration of 308.96  g 
L−1, and had only 0.25 % degradation of GABA for lasting 
30 h. Based on these results, knocking out the chromo-
somal gadA and gadB gene in E. coli might be an efficient 
metabolic engineering strategy to prevent the degrada-
tion of GABA.
Whole‑cell biocatalysis of GABA from crude Glu
Fed-batch cultivations was carried out to obtain a higher 
cell concentration (OD600 of 60) of E. coli ΔgabAB har-
boring pRB-lgadB. The bioconversion was performed in 
200 L reactor by 15 OD cells suspended in 160 L deion-
ized water with initial addition of 88.5 kg crude l-Glu at 
one time. Crude l-Glu, prepared from actual glutamate 
production process, was provided by Wuyi Gourmet 
Powder Factory. The pH of reaction mixture increased 
from 3.21 to 6.31 during 12 h conversion, and almost all 
of crude l-Glu were converted into GABA with a yield 
of 308.13  g  L−1. Although the undetermined impurities 
were existed in crude l-Glu compared to chemical pure 
l-Glu, the conversion progressed smoothly with high 
GABA production and productivity (volumetric produc-
tivity: 25.68  g  L−1  h−1, cell productivity: 24.75  g/g wet 
cell) (Fig. 6a). Notably, although our cell productivity was 
at the same level with the highest report (23–25 g/g wet 
cell), the volumetric productivity of our system was twice 
higher than that report (8–8.6 g L−1 h−1) (Plokhov et al. 
2000). Moreover, that report used thermally activated 
cells (incubation at 53 °C for 1 h) and 0.04 mM PLP in the 
cluture medium, while we did not need any pretreatment 
and addition of expensive cofactor.
The reusability of biocatalyst is a key factor for the 
efficiency of the whole-cell bioconversion in industrial 
application. Due to the highest volumetric productivity 
from 2 M l-Glu as the substrate, cycling of the recom-
binant E. coli cells was investigated using 2  M crude 
l-Glu as the initial concentration (Fig.  6b). In cycle 1, 
all l-Glu was converted to GABA in 5 h with a yield of 
204.87  g  L−1. In cycle 2, the complete conversion only 
lasted 4 h with a yield of 205.13 g L−1. However, in cycle 
3, the conversion time was increased to 6  h to achieve 
over 99 mol% conversion. Notably, cells disruption were 
observed during the bioconversion, and about 10  % or 
more cell loss after completion of each round (Addi-
tional file  1: Fig. S4). Thus, one batch of cells could be 
reused for at least three cycles at a conversion yield over 
99  mol% using 2  M crude l-Glu, and the total GABA 
production reached 614.15 g L−1 within 15 h. The high 
production and productivity of our bioconversion is a 
promising cost-effective resource for GABA in industrial 
application.
Conclusions
In this study, a process of GABA production from l-Glu 
using E. coli ΔgabAB overexpression of L. lactis GadB 
as whole-cell biocatalyst was developed. Without the 
addition of co-factor PLP, the highest GABA concen-
tration was achieved at 308.96  g  L−1 within 12  h, when 
engineered E. coli concentrated to an OD600 of 15 in 3 M 
l-Glu at 45  °C. Moreover, the engineered strain could 
be reused a three cycle successive conversion in 2  M 
crude Glu solution, and the total GABA yield reached 
614.15 g L−1. This whole-cell biocatalytic system is a cost-
effective process for industrial GABA production.
Fig. 6 Time profiles of GABA synthesis from a 3 M and b 2 M crude 
l-Glu solution. a Time course where diamond, square and circle 
represent l-Glu concentration, GABA production and pH, respectively. 
b Repeated use of cells where square, circle and diamond represent 
cycle 1, cycle 2 and cycle 3, respectively; filled shapes GABA concen-
trations; open shapes residual l-Glu concentrations
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